ShopSpell

Genes and Insurance Ethical, Legal and Economic Issues [Hardcover]

$127.99       (Free Shipping)
100 available
  • Category: Books (Business & Economics)
  • Author:  Radetzki, Marcus, Radetzki, Marian, Juth, Niklas
  • Author:  Radetzki, Marcus, Radetzki, Marian, Juth, Niklas
  • ISBN-10:  0521830907
  • ISBN-10:  0521830907
  • ISBN-13:  9780521830904
  • ISBN-13:  9780521830904
  • Publisher:  Cambridge University Press
  • Publisher:  Cambridge University Press
  • Pages:  180
  • Pages:  180
  • Binding:  Hardcover
  • Binding:  Hardcover
  • Pub Date:  01-May-2003
  • Pub Date:  01-May-2003
  • SKU:  0521830907-11-MPOD
  • SKU:  0521830907-11-MPOD
  • Item ID: 100786804
  • Seller: ShopSpell
  • Ships in: 2 business days
  • Transit time: Up to 5 business days
  • Delivery by: Dec 28 to Dec 30
  • Notes: Brand New Book. Order Now.
Considers problems associated with genetic information in an age of declining welfare provision, and offers direction for future policy.Social insurance is being partially dismantled, and the importance of private insurance is growing in consequence. Genetics has provided tools to determine the individuals' risk of future disease, which is of key interest for insurance companies in determining insurance premiums; but persons with high enough risk may remain uninsured. For this reason, genetic information has been regulated. But regulation may not be the solution, argue the authors, and suggest instead the resurrection of collectively funded public insurances. This will interest academic researchers and professonials involved with genetics and insurance.Social insurance is being partially dismantled, and the importance of private insurance is growing in consequence. Genetics has provided tools to determine the individuals' risk of future disease, which is of key interest for insurance companies in determining insurance premiums; but persons with high enough risk may remain uninsured. For this reason, genetic information has been regulated. But regulation may not be the solution, argue the authors, and suggest instead the resurrection of collectively funded public insurances. This will interest academic researchers and professonials involved with genetics and insurance.The authors of this study emphasize the effectiveness of collectively funded public insurances as opposed to genetic information regulation within the private insurance sector. Genetics has provided tools to determine individuals' risk of future disease, which is of key interest for insurance companies in determining insurance premiums; but persons with high enough risk may remain uninsured. For this reason, genetic information has been regulated. But, regulation may not be the solution, according to the authors, and they call for the resumption of social insurance, a key element of the welfare state.PrlcĄ
Add Review